review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Ka Fai To | Q99551275 |
Alfred S. Cheng | Q44364620 | ||
Wei Kang | Q56954147 | ||
P2093 | author name string | Jun Yu | |
Tingting Huang | |||
Jinglin Zhang | |||
Yuhang Zhou | |||
P2860 | cites work | A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 |
Progress and problems in understanding and managing primary Epstein-Barr virus infections | Q24597706 | ||
The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes | Q24634928 | ||
An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival | Q24649032 | ||
Epstein-Barr virus and Burkitt lymphoma | Q24669890 | ||
Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed | Q25257225 | ||
EBV-encoded miRNAs | Q84271499 | ||
Epstein-Barr virus and gastric carcinoma | Q84343974 | ||
Nasopharyngeal carcinoma | Q86035551 | ||
MicroRNAs in nasopharyngeal carcinoma | Q60594498 | ||
Endoscopic submucosal dissection of early gastric cancer | Q66829655 | ||
Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response | Q26751029 | ||
Serological diagnosis of Epstein-Barr virus infection: Problems and solutions | Q26829346 | ||
Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma | Q27024034 | ||
A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia | Q27349177 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 | ||
Identification of virus-encoded microRNAs | Q28259309 | ||
Specificity of microRNA target selection in translational repression | Q28776123 | ||
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response | Q29615493 | ||
Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing | Q33700293 | ||
Epigenetic regulation of EBV persistence and oncogenesis | Q33723664 | ||
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA | Q33971399 | ||
MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1 | Q34059350 | ||
Multiple functions are mediated by the miRNAs of Epstein-Barr virus | Q34112079 | ||
Downregulation of microRNA-200 in EBV-associated gastric carcinoma | Q34116271 | ||
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin | Q34123261 | ||
Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency | Q34236524 | ||
Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. | Q34282719 | ||
Epstein-Barr virus infection and human malignancies | Q34328170 | ||
Virus-encoded microRNAs | Q34640166 | ||
Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy | Q34720273 | ||
The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo | Q34973323 | ||
Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers | Q35083484 | ||
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. | Q35258785 | ||
Exosome and exosomal microRNA: trafficking, sorting, and function | Q35543884 | ||
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation | Q35586343 | ||
Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis | Q35641559 | ||
Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma | Q35865016 | ||
Expression profiling of microRNA using oligo DNA arrays | Q35876067 | ||
The role of miRNAs and EBV BARTs in NPC. | Q35924359 | ||
The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. | Q35924384 | ||
Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression | Q36066487 | ||
Modulation of LMP1 protein expression by EBV-encoded microRNAs | Q36092565 | ||
Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells | Q36135900 | ||
Potential Interest in Circulating miR-BART17-5p As a Post-Treatment Biomarker for Prediction of Recurrence in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma | Q36148090 | ||
Immunophenotypic characterization of Epstein-Barr virus-associated gastric carcinoma: massive infiltration by proliferating CD8+ T-lymphocytes | Q44720510 | ||
Epstein-Barr virus-positive multiple early gastric cancers and dysplastic lesions: a case report | Q44839906 | ||
High-density methylation of p14ARF and p16INK4A in Epstein-Barr virus-associated gastric carcinoma | Q45592381 | ||
Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach | Q45744646 | ||
Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ | Q45775585 | ||
Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. | Q45775808 | ||
Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. | Q45851280 | ||
Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells | Q47978435 | ||
miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. | Q36368456 | ||
Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. | Q36457063 | ||
Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis | Q36481462 | ||
The expression of a viral microRNA is regulated by clustering to allow optimal B cell transformation | Q36588894 | ||
An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro | Q36628631 | ||
Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma | Q36782643 | ||
Evolutionarily conserved function of a viral microRNA. | Q36933925 | ||
Epstein-Barr virus maintains lymphomas via its miRNAs. | Q36948327 | ||
Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. | Q36978556 | ||
Regulation of viral oncogenesis by microRNAs | Q36997713 | ||
Spectrum of Epstein-Barr virus-associated diseases | Q37014791 | ||
NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma. | Q37073277 | ||
Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma | Q37212310 | ||
Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103. | Q37330822 | ||
Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1. | Q37392833 | ||
Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22 | Q37399274 | ||
Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells | Q37547400 | ||
Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas. | Q37693416 | ||
High level of viral microRNA-BART20-5p expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer | Q37716478 | ||
Epstein-Barr virus and Burkitt lymphoma. | Q38270680 | ||
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. | Q38307191 | ||
Update on Epstein-Barr virus and gastric cancer (review). | Q38336778 | ||
Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma | Q38480025 | ||
A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer | Q38518045 | ||
Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers. | Q38765494 | ||
Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers | Q38805572 | ||
EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. | Q38944897 | ||
Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells. | Q39124304 | ||
Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay | Q39711736 | ||
The EB virus | Q39899178 | ||
Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. | Q39903979 | ||
Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms. | Q40048502 | ||
Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in Epstein-Barr virus-associated gastric cancer: the prognostic implications | Q40416586 | ||
Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma | Q40754381 | ||
Comprehensive profiling of virus microRNAs of Epstein-Barr virus-associated gastric carcinoma: highlighting the interactions of ebv-Bart9 and host tumor cells | Q40769652 | ||
Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor | Q41593065 | ||
Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas | Q42007977 | ||
EBV and human cancer | Q43128039 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
carcinogenesis | Q1637543 | ||
stomach neoplasm | Q4335552 | ||
Epstein–Barr virus | Q6900 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 38-45 | |
P577 | publication date | 2017-10-09 | |
2018-01-01 | |||
P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
P1476 | title | The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma | |
P478 | volume | 22 |
Q55024423 | Epstein-Barr virus-encoded microRNAs as regulators in host immune responses. |
Q57490871 | Herpesviruses and MicroRNAs: New Pathogenesis Factors in Oral Infection and Disease? |
Q89879454 | High Levels of Class I Major Histocompatibility Complex mRNA Are Present in Epstein-Barr Virus-Associated Gastric Adenocarcinomas |
Q99234080 | High MHC-II expression in Epstein-Barr virus-associated gastric cancers suggests that tumor cells serve an important role in antigen presentation |
Q59357066 | Latent Membrane Protein 1 of Epstein-Barr Virus Promotes RIG-I Degradation Mediated by Proteasome Pathway |
Q104795011 | Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses |
Q91642752 | Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence |
Q58798762 | The Epstein Barr virus circRNAome |
Search more.